326 related articles for article (PubMed ID: 11739688)
41. Multiple functions within the Epstein-Barr virus EBNA-3A protein.
Cludts I; Farrell PJ
J Virol; 1998 Mar; 72(3):1862-9. PubMed ID: 9499037
[TBL] [Abstract][Full Text] [Related]
42. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.
Cooper A; Johannsen E; Maruo S; Cahir-McFarland E; Illanes D; Davidson D; Kieff E
J Virol; 2003 Jan; 77(2):999-1010. PubMed ID: 12502816
[TBL] [Abstract][Full Text] [Related]
43. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
Tsang SF; Wang F; Izumi KM; Kieff E
J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
[TBL] [Abstract][Full Text] [Related]
44. Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells.
Cotter M; Callahan J; Aster J; Robertson E
J Virol; 2000 Feb; 74(3):1486-94. PubMed ID: 10627560
[TBL] [Abstract][Full Text] [Related]
45. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.
Chen F; Zou JZ; di Renzo L; Winberg G; Hu LF; Klein E; Klein G; Ernberg I
J Virol; 1995 Jun; 69(6):3752-8. PubMed ID: 7745723
[TBL] [Abstract][Full Text] [Related]
46. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
[TBL] [Abstract][Full Text] [Related]
47. Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation.
Dalbiès-Tran R; Stigger-Rosser E; Dotson T; Sample CE
J Virol; 2001 Jan; 75(1):90-9. PubMed ID: 11119577
[TBL] [Abstract][Full Text] [Related]
48. Structure and function of the Epstein-Barr virus transcription factor, EBNA 3C.
West MJ
Curr Protein Pept Sci; 2006 Apr; 7(2):123-36. PubMed ID: 16611138
[TBL] [Abstract][Full Text] [Related]
49. EBNA2 and Its Coactivator EBNA-LP.
Kempkes B; Ling PD
Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
[TBL] [Abstract][Full Text] [Related]
50. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
51. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
52. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
[TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.
Maruo S; Wu Y; Ito T; Kanda T; Kieff ED; Takada K
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4419-24. PubMed ID: 19237563
[TBL] [Abstract][Full Text] [Related]
55. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Blood; 2011 Jan; 117(1):165-74. PubMed ID: 20876453
[TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
57. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.
Sinclair AJ; Palmero I; Peters G; Farrell PJ
EMBO J; 1994 Jul; 13(14):3321-8. PubMed ID: 8045261
[TBL] [Abstract][Full Text] [Related]
58. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
59. Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Begić V; Korać P; Gašparov S; Rozman M; Simicic P; Zidovec-Lepej S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555277
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.
Tursiella ML; Bowman ER; Wanzeck KC; Throm RE; Liao J; Zhu J; Sample CE
PLoS Pathog; 2014 Oct; 10(10):e1004415. PubMed ID: 25275486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
